Sander L D, Porter J R
Life Sci. 1982 Sep 13;31(11):1103-10. doi: 10.1016/0024-3205(82)90083-2.
The influence of cholecystokinin 33 (CCK33) on CRF-like stimulation of ACTH output was tested in vitro using isolated pituitary cells. ACTH was assayed using isolated adrenal cell preparations. The CRF-like material was contained in a crude acetic-acid extract of hypothalamic stalk median eminence (HSME). CCK33, in doses of 1 U, 10(-3) U, and 10(-6) U/ml cell suspension had no influence on basal or ACTH-stimulated corticosterone output from isolated adrenal cells. Isolated pituitary cells responded in a dose-related fashion of HSME extract, however, the absolute response to a given dose of HSME extract varied according to the basal (non-stimulated) output of a particular cell preparation. CCK33, in the dose range tested, had no influence on basal ACTH output. In contrast, 10(-3) U/ml oc CCK33, which corresponds to a concentration of 8 X 10(-11) M, significantly inhibited the output of ACTH from isolated pituitary cells stimulated by 0.2 equivalents of HSME. Higher concentrations of CCK33 had a variable effect. We conclude that cholecystokinin may have a role in the regulation of HSME-stimulated ACTH output from the pituitary.
利用分离的垂体细胞在体外试验了胆囊收缩素33(CCK33)对促肾上腺皮质激素释放因子(CRF)样刺激促肾上腺皮质激素(ACTH)分泌的影响。采用分离的肾上腺细胞制剂测定ACTH。CRF样物质存在于下丘脑柄正中隆起(HSME)的粗乙酸提取物中。CCK33,剂量为1 U、10⁻³ U和10⁻⁶ U/ml细胞悬液,对分离的肾上腺细胞的基础或ACTH刺激的皮质酮分泌没有影响。然而,分离的垂体细胞对HSME提取物呈剂量相关反应,不过,对给定剂量的HSME提取物的绝对反应根据特定细胞制剂的基础(未刺激)分泌量而有所不同。在所测试的剂量范围内,CCK33对基础ACTH分泌没有影响。相反,10⁻³ U/ml的CCK33(相当于8×10⁻¹¹ M的浓度)显著抑制了由0.2当量的HSME刺激的分离垂体细胞的ACTH分泌。更高浓度的CCK33具有可变效应。我们得出结论,胆囊收缩素可能在调节HSME刺激垂体分泌ACTH中起作用。